Lithuania has emerged as a global leader in biotechnology, with a sector that has grown over 170% in recent years and a national commitment to reach 5% of the country’s GDP by 2030. This thriving ecosystem provides the ideal, high-innovation landscape to accelerate your molecule from concept to commercial reality.
Our Innovative Centre is purpose-built to support three interconnected areas of advanced biomedical research and development. We provide dedicated infrastructure and expertise for cell therapy development and manufacturing, personalized therapeutic vaccine production, and 3D bioprinting and tissue engineering – bringing together the capabilities needed to advance the next generation of regenerative and personalized medicine.
Number of R&D laboratories
Cell Therapy facility size (m2)
